像许多其他药物研究领域一样，小型生物工学公司正逐渐取代传统的医药界巨擘进行抗生素研究。
Like some other areas of drug research, though, it is increasingly the province of boutique biotechnology firms, rather than the huge emporia that are traditional pharmaceutical companies.
他们给受保护的小鼠一到两种抗生素药物治疗，用低剂量来改变各种微生物的丰富性但不是杀死这些微生物。
They gave protected mice one of two antibiotic drugs in low doses that altered the abundance of various microbes but didn't kill the bugs.
使用单一药物尤其是青蒿素及其衍生物的单一药物治疗疟疾可能会增加耐药性。
The likelihood of drug resistance is increased with the use of single-drug therapies for malaria, especially monotherapies of artemisinin and its derivatives.
青蒿素衍生物是如今使用的药物的基础。
双氢青蒿素是青蒿素类药物中活性较强的衍生物。
Dihydroartemisinin is one of the derivatives with higher activity.
即使在形成生物膜的细菌缺乏抗生素耐药基因的情况下，这些生物膜对抗生素药物的耐受程度仍远远高于未被生物膜包裹的细菌。
Biofilms, which are far tougher than bacteria not incorporated into biofilms, are resistant to antibiotics even when the individual bacteria composing the biofilm lack antibiotic resistance genes.
某些抗生素药物、生物活性物质在水生动物机体中的残留，往往直接影响着人类的健康。
Some antibiotic medicines, residue in aquatic animal's organism of active material of living beings, often influencing the human health directly.
为了提高新型抗生素agpm的生产以及获得类似结构新药物，本论文首次开展其生物合成和调控机制的研究。
To increase its production and obtain new pharmaceuticals of similar structure, the novel antibiotic AGPM biosynthesis and regulation mechanism was studied in this dissertation.
天麻素衍生物，其制备方法，药物组合物及其用途。
Gastrodine derivative, its preparation method, pharmaceutical composition and USES.
本文综述了纤维素衍生物在固定酶和药物中的应用。
In this paper, the application of cellulose derivatives in immobilization of enzymes and drugs is reviewed.
温和的操作温度对生物制品、抗生素药物和药物载体的微细化尤其适用。
A mild operating temperature may provide ideal conditions for processing biomedical drug, antibiotics and pharmaceutical carrier.
替加环素为新型抗菌甘氨环素类药物，即米诺环素的衍生物，能够克服与四环素类绝大部分相关的耐药机制。
Tigecycline, the first in a new class of antimicrobials, the glycylcyclines, is an analogue of minocycline with additional properties that negate most mechanisms mediating resistance to the tetra.
本文在介绍青蒿素抗疟疾作用、应用和作用机制的基础上，对近年来青蒿素类药物的其它主要生物学作用研究的现状进行综述。
Based on an introduction of the conventional actions and mechanisms of these drugs, we reviewed the recent progress of their new biological...
微生物理论慢慢地取得了胜利——但是，直到出现了磺胺类药物和抗生素之前，战胜细菌的唯一方法几乎也还是将它们洗掉。
The germ theory slowly triumphed - but until the development of sulfa and antibiotics, almost the only way to fight microbes was by washing them off.
这是因为一般来说，抗生素作为治疗药物，微生物获得抗药性的遗传能力，这导致制药行业出现了问题。
This is because in general, microorganisms have the genetic ability to acquire multi resistances to antibiotic used as therapeutic agents and this have caused problems to pharmaceutical industries.
喹诺酮类、 大环内酯类、抗感染中成药类抗感染药物以及生物制品与生化药物、维生素类药物均有增长；
Anti-infectious agents like quinolones, macrolides, TCM with anti-infectious effect and biologicals & biochemicals, vitamins had grown.
这类4-羟基香豆素衍生物是一类口服抗凝血药物。
Such 4 - hydroxycoumarin derivatives are a class of oral anti-clotting drugs.
然而，截至2004年的150多种生物药中，以晶体为其主要的生产和销售形态的药物只有胰岛素。
However, among the about 150 biopharmaceuticals on the market by 2004, only insulin has been marketed in crystalline form.
本文概述目前探索用于针对肿瘤坏死因子、干扰素、细胞因子等靶点治疗CD的一些生物药物。
Some biological drugs that are currently explored for therapy CD targeting at tumor necrosis factors, interferons, cytokines and so on a...
青蒿素类药物是治疗疟疾的主要药物，其衍生物有青蒿琥酯、蒿甲醚和二氢青蒿素等，主要的作用机制是通过铁离子介导的细胞损伤。
Artemisinins are the major drugs of antimalarial. Its derivatives include artesunate, artemether, dihydroartemisinin and etc. Artemisinins exert their antimalarial activity by iron-mediated cleavage.
我们提供反应荧光探针和发光探针，生物素和端粒酶能够应用于标记药物小分子和生物聚合物，如蛋白、核酸以及其他碳水化合物；
Our reactive fluorescent and luminescent probes, biotins and tag enzymes are used for labeling small drug molecules and biopolymers, e. g, proteins, nucleic acids and carbohydrates;
本发明属药物合成领域，涉及丹参素衍生物。
The invention belongs to the field of medicament synthesis, and relates to a Danshensu derivative.
一种靛玉红衍生物新的医药用途，是靛玉红衍生物在制备治疗非胰岛素依赖性糖尿病药物中的应用。
The present invention relates to the medicinal use of indirubin derivative, and is especially the application of indirubin derivative in preparing medicine for treating non-insulin dependent diabetes.
一种靛玉红衍生物新的医药用途，是靛玉红衍生物在制备治疗非胰岛素依赖性糖尿病药物中的应用。
The present invention relates to the medicinal use of indirubin derivative, and is especially the application of indirubin derivative in preparing medicine for treating non-insulin dependent diabetes.
应用推荐